Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Analysts at Truist Securiti lowered their FY2021 EPS estimates for Walgreens Boots Alliance in a note issued to investors on Monday, April 5th. Truist Securiti analyst D. Macdonald now anticipates that the pharmacy operator will earn $4.62 per share for the year, down from their prior estimate of $4.80.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, March 30th. The pharmacy operator reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.30. The business had revenue of $32.78 billion for the quarter, compared to analyst estimates of $36.16 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The firm’s quarterly revenue was down 8.5% on a year-over-year basis. During the same period last year, the business posted $1.52 earnings per share.
A number of other equities research analysts have also issued reports on the company. Truist Securities lifted their target price on Walgreens Boots Alliance from $50.00 to $58.00 in a research report on Thursday, April 1st. Morgan Stanley lifted their price objective on shares of Walgreens Boots Alliance from $40.00 to $52.00 and gave the company an “equal weight” rating in a report on Tuesday, March 30th. Guggenheim upgraded shares of Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a report on Monday, January 11th. Barclays lifted their price target on shares of Walgreens Boots Alliance from $47.00 to $55.00 and gave the company an “equal weight” rating in a research note on Monday. Finally, Credit Suisse Group increased their price objective on shares of Walgreens Boots Alliance from $46.00 to $50.00 and gave the stock a “neutral” rating in a research note on Thursday, April 1st. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $48.59.
Shares of Walgreens Boots Alliance stock opened at $55.58 on Thursday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.32. The firm has a market cap of $48.02 billion, a price-to-earnings ratio of 111.16, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The stock’s 50-day moving average is $51.08 and its 200-day moving average is $43.77. Walgreens Boots Alliance has a one year low of $33.36 and a one year high of $57.05.
Hedge funds have recently bought and sold shares of the stock. Public Sector Pension Investment Board lifted its position in Walgreens Boots Alliance by 22.3% during the third quarter. Public Sector Pension Investment Board now owns 86,928 shares of the pharmacy operator’s stock worth $3,122,000 after acquiring an additional 15,840 shares during the last quarter. Engineers Gate Manager LP boosted its stake in Walgreens Boots Alliance by 257.1% in the 3rd quarter. Engineers Gate Manager LP now owns 65,202 shares of the pharmacy operator’s stock valued at $2,342,000 after purchasing an additional 46,945 shares during the period. First City Capital Management Inc. grew its holdings in Walgreens Boots Alliance by 59.3% in the 3rd quarter. First City Capital Management Inc. now owns 14,595 shares of the pharmacy operator’s stock valued at $524,000 after buying an additional 5,435 shares in the last quarter. Squarepoint Ops LLC bought a new position in Walgreens Boots Alliance during the 3rd quarter worth $9,453,000. Finally, Advisory Alpha LLC acquired a new stake in shares of Walgreens Boots Alliance during the third quarter worth $34,000. 55.96% of the stock is currently owned by institutional investors and hedge funds.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were given a $0.4675 dividend. The ex-dividend date of this dividend was Thursday, February 18th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 3.36%. Walgreens Boots Alliance’s payout ratio is 39.45%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Recommended Story: Hedge Funds – Risk or Reward?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.